Molecular MedicinePublished 18 September 2024DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndromeGrace Haroun · Erlinda M. GordonFrontiers in Molecular Medicinedoi 10.3389/fmmed.2024.1461151